SUDEEPPHRM — Sudeep Pharma Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹113.03bn
- IN₹113.48bn
- IN₹6.39bn
Annual cashflow statement for Sudeep Pharma, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 685 | 860 | 1,748 | 1,828 | 2,281 |
| Depreciation | |||||
| Non-Cash Items | 10.8 | 99.9 | 44.5 | 48.6 | -57.9 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -770 | -555 | -1,226 | -1,496 | -1,638 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -26.4 | 484 | 657 | 487 | 733 |
| Capital Expenditures | -578 | -472 | -525 | -642 | -1,181 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 193 | -28.6 | 31.8 | -145 | -2,128 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -384 | -500 | -493 | -788 | -3,309 |
| Financing Cash Flow Items | -18.2 | -46.5 | -37.6 | -54.2 | -180 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 506 | -97.8 | -127 | 527 | 2,473 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 95.2 | -112 | 36.7 | 228 | -101 |